Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab - the ReWoLuTe Study
NCT07510724 · RECRUITING · N/A
We track 1 ClinicalTrials.gov studies led by Institut FüR Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest. The portfolio skews toward N/A (1 trials).
1 clinical trials sponsored by Institut FüR Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 1 | 100% |
Institut FüR Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest currently sponsors 1 clinical trials tracked on ReadTheTrial. These span N/A.
Institut FüR Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Institut FüR Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.